An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Nuclear scientists at Oak Ridge National Laboratory have established a Nuclear Quality Assurance-1 program for a software product designed to simulate today’s commercial nuclear reactors – removing a significant barrier for industry adoption of the technology.